Item 16. FORM 10-K SUMMARY

None.

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this Annual Report on Form 10-K to be signed on its behalf by the undersigned, thereunto duly authorized.


			NEWMONT CORPORATION

			By:			/s/ PETER I. WEXLER
						Executive Vice President, Chief Legal Officer, and Interim Chief Financial Officer
						February 19, 2026

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities indicated on February 19, 2026.


Signature						Title

*****						President, Chief Executive Officer and Director
Natascha Viljoen						(Principal Executive Officer)

*****						Executive Vice President, Chief Legal Officer, and Interim Chief Financial Officer
Peter I. Wexler						(Principal Financial Officer)

*****						Senior Vice President, Global Finance and Chief Accounting Officer
Brian C. Tabolt						(Principal Accounting Officer)

Gregory H. Boyce*						Non-Executive Chair

Bruce R. Brook*						Director

Maura J. Clark*						Director

Harry M. Conger, IV*						Director

Emma FitzGerald*						Director

Sally-Anne Layman*						Director

José Manuel Madero Garza*						Director

René Médori*						Director

Jane Nelson*						Director

Julio M. Quintana*						Director

David Seaton*						Director



*By:			/s/ PETER I. WEXLER
			Peter I. Wexler Attorney-in-Fact

SCH- 1

SCHEDULE II-VALUATION AND QUALIFYING ACCOUNTS

(dollars in millions except per share)


	Year Ended December 31,
	2025		2024		2023
Deferred Income Tax Valuation Allowance
Balance at beginning of year	$	4,363	$	4,652	$	3,994
Additions due to acquisition of Newcrest	—		168		300
Additions to deferred income tax expense	498		80		565
Reduction of deferred income tax expense	(203)		(382)		(207)
Additions and reductions reflected in other components of the financial statements	124		(155)		—
Balance at end of year	$	4,782	$	4,363	$	4,652

Refer to Note 10 to the Consolidated Financial Statements for additional information.

SCH- 2

Previous: Item 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES